We demonstrate barrier function loss and recovery in response to damaging cytokines Tumor Necrosis Factor alpha (TNF-α) and Interferon gamma (IFN-γ), both recognized drivers of IBD in vivo, in a dose-dependent and reproducible manner33. Here, TNF is linked to inflammatory bowel disease.